Logo image of ALSPT.PA

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

Europe - EPA:ALSPT - FR00140043Y1 - Common Stock

0.32 EUR
+0.01 (+1.91%)
Last: 11/19/2025, 7:00:00 PM
Fundamental Rating

3

ALSPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 52 industry peers in the Specialty Retail industry. ALSPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALSPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALSPT has reported negative net income.
ALSPT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALSPT reported negative net income in multiple years.
In multiple years ALSPT reported negative operating cash flow during the last 5 years.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.58%, ALSPT is doing worse than 63.46% of the companies in the same industry.
ALSPT's Return On Equity of -7.11% is on the low side compared to the rest of the industry. ALSPT is outperformed by 65.38% of its industry peers.
ALSPT has a better Return On Invested Capital (11.65%) than 80.77% of its industry peers.
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROIC 11.65%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Operating Margin of ALSPT (5.49%) is better than 73.08% of its industry peers.
In the last couple of years the Operating Margin of ALSPT has grown nicely.
ALSPT has a better Gross Margin (50.85%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of ALSPT has remained more or less at the same level.
Industry RankSector Rank
OM 5.49%
PM (TTM) N/A
GM 50.85%
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

ALSPT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ALSPT has been increased compared to 1 year ago.
The debt/assets ratio for ALSPT has been reduced compared to a year ago.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ALSPT has an Altman-Z score of 1.87. This is not the best score and indicates that ALSPT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.87, ALSPT perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
ALSPT has a debt to FCF ratio of 3.27. This is a good value and a sign of high solvency as ALSPT would need 3.27 years to pay back of all of its debts.
ALSPT has a Debt to FCF ratio of 3.27. This is in the better half of the industry: ALSPT outperforms 78.85% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that ALSPT is not too dependend on debt financing.
ALSPT's Debt to Equity ratio of 0.44 is in line compared to the rest of the industry. ALSPT outperforms 59.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Altman-Z 1.87
ROIC/WACC2.03
WACC5.73%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

ALSPT has a Current Ratio of 1.95. This is a normal value and indicates that ALSPT is financially healthy and should not expect problems in meeting its short term obligations.
ALSPT's Current ratio of 1.95 is amongst the best of the industry. ALSPT outperforms 82.69% of its industry peers.
ALSPT has a Quick Ratio of 1.95. This is a bad value and indicates that ALSPT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.65, ALSPT is in line with its industry, outperforming 57.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 0.65
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

ALSPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.74%.
Looking at the last year, ALSPT shows a decrease in Revenue. The Revenue has decreased by -7.50% in the last year.
The Revenue has been decreasing by -4.60% on average over the past years.
EPS 1Y (TTM)-69.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%

3.2 Future

The Earnings Per Share is expected to grow by 28.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALSPT will show a decrease in Revenue. The Revenue will decrease by -2.10% on average per year.
EPS Next Y-25%
EPS Next 2Y27.48%
EPS Next 3Y28.56%
EPS Next 5YN/A
Revenue Next Year-8.43%
Revenue Next 2Y-3.85%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.
Also next year ALSPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 100.00% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than ALSPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.1
EV/EBITDA 0.85
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

ALSPT's earnings are expected to grow with 28.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3Y28.56%

0

5. Dividend

5.1 Amount

No dividends for ALSPT!.
Industry RankSector Rank
Dividend Yield N/A

SPARTOO

EPA:ALSPT (11/19/2025, 7:00:00 PM)

0.32

+0.01 (+1.91%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.75%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.85M
Revenue(TTM)125.12M
Net Income(TTM)-2.05M
Analysts82
Price Target0.82 (156.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)50%
EPS NY rev (3m)50%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.1
P/OCF 1
P/B 0.2
P/tB 0.24
EV/EBITDA 0.85
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.29
FCFY91.19%
OCF(TTM)0.32
OCFY100.13%
SpS6.84
BVpS1.58
TBVpS1.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.58%
ROE -7.11%
ROCE 15.85%
ROIC 11.65%
ROICexc 15.48%
ROICexgc 18.18%
OM 5.49%
PM (TTM) N/A
GM 50.85%
FCFM 4.26%
ROA(3y)-3.05%
ROA(5y)-1%
ROE(3y)-9.05%
ROE(5y)-1.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y13.91%
ROICexgc growth 5YN/A
ROICexc growth 3Y13.21%
ROICexc growth 5YN/A
OM growth 3Y26.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5YN/A
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.27
Debt/EBITDA 0.86
Cap/Depr 6.61%
Cap/Sales 0.42%
Interest Coverage 250
Cash Conversion 39.62%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 0.65
Altman-Z 1.87
F-Score6
WACC5.73%
ROIC/WACC2.03
Cap/Depr(3y)16.79%
Cap/Depr(5y)31.52%
Cap/Sales(3y)0.76%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y-25%
EPS Next 2Y27.48%
EPS Next 3Y28.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.5%
Revenue growth 3Y-4.6%
Revenue growth 5YN/A
Sales Q2Q%-8.19%
Revenue Next Year-8.43%
Revenue Next 2Y-3.85%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A
EBIT growth 1Y123.58%
EBIT growth 3Y20.46%
EBIT growth 5YN/A
EBIT Next Year315.84%
EBIT Next 3Y72.78%
EBIT Next 5YN/A
FCF growth 1Y135.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y142.61%
OCF growth 3YN/A
OCF growth 5YN/A

SPARTOO / ALSPT.PA FAQ

What is the fundamental rating for ALSPT stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPT.PA.


What is the valuation status for ALSPT stock?

ChartMill assigns a valuation rating of 3 / 10 to SPARTOO (ALSPT.PA). This can be considered as Overvalued.


Can you provide the profitability details for SPARTOO?

SPARTOO (ALSPT.PA) has a profitability rating of 3 / 10.